Skip to main content
. 2020 Sep 22;12(9):899. doi: 10.3390/pharmaceutics12090899

Table 2.

Recommended fragmentation patterns.

Tazarotene
graphic file with name pharmaceutics-12-00899-i013.jpg
TP-1
graphic file with name pharmaceutics-12-00899-i014.jpg
TP-2
graphic file with name pharmaceutics-12-00899-i015.jpg
TP-3
graphic file with name pharmaceutics-12-00899-i016.jpg
TP-4
graphic file with name pharmaceutics-12-00899-i017.jpg
TP-5
graphic file with name pharmaceutics-12-00899-i018.jpg
TP-6
graphic file with name pharmaceutics-12-00899-i019.jpg
TP-7
graphic file with name pharmaceutics-12-00899-i020.jpg
TP-8
graphic file with name pharmaceutics-12-00899-i021.jpg
TP-9
graphic file with name pharmaceutics-12-00899-i022.jpg
TP-10
graphic file with name pharmaceutics-12-00899-i023.jpg
TP-11
graphic file with name pharmaceutics-12-00899-i024.jpg